AMANDA HOELSCHER: Open Payments
NPI 1700282886 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,755 in 127 payments from 14 companies in 2025. Trend: 2023 $638 · 2024 $1,145 · 2025 $2,755
Food & beverage: $2,128Speaker / faculty: $450Education: $178
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 64 | $1,302 |
| Janssen Biotech, Inc. | 6 | $430 |
| PFIZER INC. | 18 | $373 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $203 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
| Lilly USA, LLC | 3 | $78 |
| Ardelyx, Inc. | 2 | $57 |
| Janssen Scientific Affairs, LLC | 1 | $54 |
| Phathom Pharmaceuticals, Inc. | 5 | $39 |
| VIVUS LLC | 2 | $36 |
Products named: RINVOQ, TREMFYA, SKYRIZI, VELSIPITY, ENTYVIO, CREON, XELJANZ, STELARA.
Industry payments across TX — which companies pay providers there.
